Published in Br Med J (Clin Res Ed) on March 12, 1988
The natural history and functional consequences of dysphagia after hemispheric stroke. J Neurol Neurosurg Psychiatry (1989) 2.00
Acute ischaemic stroke. BMJ (2000) 1.52
Effect of beta-blocker therapy on the risk of infections and death after acute stroke--a historical cohort study. PLoS One (2015) 1.49
Treating hypertension after stroke. BMJ (1994) 1.20
Drugs in cerebral and peripheral arterial disease. BMJ (1990) 0.98
MR perfusion imaging in acute ischemic stroke. Neuroimaging Clin N Am (2011) 0.89
Effects of early blood pressure lowering on early and long-term outcomes after acute stroke: an updated meta-analysis. PLoS One (2014) 0.83
Unsolved issues in the management of high blood pressure in acute ischemic stroke. Int J Hypertens (2013) 0.79
Stroke management. BMJ Clin Evid (2011) 0.77
The Beta-1-Receptor Blocker Nebivolol Elicits Dilation of Cerebral Arteries by Reducing Smooth Muscle [Ca2+]i. PLoS One (2016) 0.75
Effect of β-Adrenergic Antagonists on In-Hospital Mortality after Ischemic Stroke. J Stroke Cerebrovasc Dis (2015) 0.75
A stress-related explanation to the increased blood pressure and its course following ischemic stroke. Vasc Health Risk Manag (2016) 0.75
Modulation of Cardiac Autonomic Dysfunction in Ischemic Stroke following Ayurveda (Indian System of Medicine) Treatment. Evid Based Complement Alternat Med (2014) 0.75
Blood Pressure Reduction in the Acute Phase of an Ischemic Stroke Does Not Improve Short- or Long-Term Dependency or Mortality: A Meta-Analysis of Current Literature. Medicine (Baltimore) (2015) 0.75
Blood pressure management in acute stroke. Stroke Vasc Neurol (2016) 0.75
Increased infections with β-blocker use in ischemic stroke, a β2-receptor mediated process? Neurol Sci (2017) 0.75
Cerebrovascular disease in the community: results of a WHO collaborative study. Bull World Health Organ (1980) 5.66
Effect of propranolol and phentolamine on myocardial necrosis after subarachnoid haemorrhage. Br Med J (1978) 1.84
Beta-adrenoceptor blockers and the blood-brian barrier. Br J Clin Pharmacol (1981) 1.60
Beneficial effects of adrenergic blockade in patients with subarachnoid haemorrhage. Br Med J (Clin Res Ed) (1982) 1.27
Measuring functional outcomes in therapeutic trials for chronic disease. Control Clin Trials (1984) 1.23
The pragmatic approach to stroke trial design: stroke register, pilot trial, assessment of neurological then functional outcome. Neuroepidemiology (1988) 1.07
Towards a model stroke trial. The single-centre naftidrofuryl study. Neuroepidemiology (1986) 1.04
Double-blind randomised trial of intravenous glycerol in acute stroke. Lancet (1987) 1.02
Cerebral metabolic changes during treatment of subacute cerebral infarction by alpha and beta adrenergic blockade with phenoxybenzamine and propranolol. Stroke (1974) 0.91
Treatment of acute focal cerebral ischemia with propranolol. Stroke (1982) 0.90
Problems in design of stroke treatment trials. Stroke (1982) 0.89
Relative contributions of history-taking, physical examination, and laboratory investigation to diagnosis and management of medical outpatients. Br Med J (1975) 9.18
Acetaminophen-induced hepatic necrosis. IV. Protective role of glutathione. J Pharmacol Exp Ther (1973) 5.23
Benefits and potential harm of lowering high blood pressure. Lancet (1987) 4.88
Acetaminophen-induced hepatic necrosis. I. Role of drug metabolism. J Pharmacol Exp Ther (1973) 4.40
Bromobenzene-induced liver necrosis. Protective role of glutathione and evidence for 3,4-bromobenzene oxide as the hepatotoxic metabolite. Pharmacology (1974) 4.32
A randomised trial of home-versus-hospital management for patients with suspected myocardial infarction. Lancet (1978) 4.12
Falls by elderly people at home: prevalence and associated factors. Age Ageing (1988) 3.92
Acetaminophen-induced hepatic necrosis. II. Role of covalent binding in vivo. J Pharmacol Exp Ther (1973) 3.89
Interim discharge summaries: how are they best delivered to general practitioners? Br Med J (Clin Res Ed) (1987) 3.64
Once-daily dosing with Atenolol in patients with mild or moderate hypertension. Br Med J (1976) 3.64
Menopausal flushing: does oestrogen therapy make sense? Lancet (1976) 3.47
Self-poisoning: management of patients in Nottingham, 1976. Br Med J (1978) 3.24
Levels of customary physical activity among the old and the very old living at home. J Epidemiol Community Health (1988) 3.07
Acetaminophen-induced hepatic injury: protective role of glutathione in man and rationale for therapy. Clin Pharmacol Ther (1974) 2.62
Accumulation and elimination of poliovirus by the eastern oyster. Am J Epidemiol (1966) 2.58
Randomised placebo-controlled trial comparing oxprenolol with disopyramide phosphate in immediate treatment of suspected myocardial infarction. Lancet (1980) 2.53
Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men. Lancet (1995) 2.36
Isoniazid liver injury: clinical spectrum, pathology, and probable pathogenesis. Ann Intern Med (1976) 2.33
Randomised trial comparing propranolol with atenolol in immediate treatment of suspected myocardial infarction. Br Med J (1980) 2.32
Guanethidine and related agents. 3. Antagonism by drugs which inhibit the norepinephrine pump in man. J Clin Invest (1970) 2.29
RNA binding domain of telomerase reverse transcriptase. Mol Cell Biol (2001) 2.27
Effect of a pyrimidopyrimidine derivative on thrombus formation in the rabbit. Nature (1965) 2.19
Is nursing any business of doctors? A simple guide to the "nursing process". Br Med J (Clin Res Ed) (1984) 2.17
Early reporting of myocardial infarction: impact of an experiment in patient education. Br Med J (Clin Res Ed) (1982) 2.11
Isoniazid-associated hepatitis in 114 patients. Gastroenterology (1975) 2.02
Platelet reactivity and serum thromboxane B2 production in whole blood in gestational hypertension and pre-eclampsia. Br J Obstet Gynaecol (1991) 1.91
Acetaminophen-induced hepatic necrosis. 3. Cytochrome P-450-mediated covalent binding in vitro. J Pharmacol Exp Ther (1973) 1.90
Effect of prostaglandin E1 on platelet behaviour in vitro and in vivo. Br Med J (1967) 1.85
Effect of propranolol and phentolamine on myocardial necrosis after subarachnoid haemorrhage. Br Med J (1978) 1.84
Extracts of feverfew inhibit granule secretion in blood platelets and polymorphonuclear leucocytes. Lancet (1985) 1.84
The hydration structure of guanidinium and thiocyanate ions: implications for protein stability in aqueous solution. Proc Natl Acad Sci U S A (2003) 1.83
An association between abo blood-group distribution and geographical differences in death-rates. Lancet (1977) 1.81
Effect of dipyridamole on human platelet behaviour. Lancet (1965) 1.79
Plasma glutathione and glutathione disulfide in the rat: regulation and response to oxidative stress. J Pharmacol Exp Ther (1983) 1.79
Increased incidence of isoniazid hepatitis in rapid acetylators: possible relation to hydranize metabolites. Clin Pharmacol Ther (1975) 1.75
Oxidation of alpha-methyldopa and other catechols by cytochrome P-450-generated superoxide anion: possible mechanism of methyldopa hepatitis. Mol Pharmacol (1976) 1.73
Atenolol in the treatment of pregnancy-induced hypertension. Br J Clin Pharmacol (1981) 1.73
Dexamethasone in acute stroke. Br Med J (1978) 1.73
Acetaminophen-induced hepatic necrosis. VI. Metabolic disposition of toxic and nontoxic doses of acetaminophen. Pharmacology (1974) 1.70
Is an information booklet for patients leaving hospital helpful and useful? BMJ (1989) 1.68
Antagonism of the antihypertensive action of guanethidine sulfate by desipramine hydrochloride. JAMA (1967) 1.67
What constitutes evidence on the dietary prevention of coronary heart disease? Cosy beliefs or harsh facts? Int J Cardiol (1984) 1.66
Randomised double-blind placebo-controlled trial of feverfew in migraine prevention. Lancet (1988) 1.62
The clinical importance of cardioselectivity and lipophilicity in beta blockers. Am Heart J (1980) 1.61
Beta-adrenoceptor blockers and the blood-brian barrier. Br J Clin Pharmacol (1981) 1.60
Comparison of atenolol and oxprenolol in patients with angina or hypertension and co-existent chronic airways obstruction. Br J Clin Pharmacol (1978) 1.59
The role of the interview in student selection. S Afr Med J (1978) 1.59
Autumn Books: Who needs Clinical Pharmacology? Br Med J (Clin Res Ed) (1984) 1.57
"But will it help my patients with myocardial infarction?" The implications of recent trials for everyday country folk. Br Med J (Clin Res Ed) (1982) 1.55
Effect of aggregating agents on the electrophoretic mobility of human platelets. Br Med J (1966) 1.55
Prevention and diagnosis of venous thrombosis in patients with hip fractures. A survey of current practice. Lancet (1976) 1.52
Blood pressure reduction in elderly: a randomised controlled trial of methyldopa. Br Med J (Clin Res Ed) (1981) 1.52
The effect of age, sex, parity, haemoglobin level, and oral contraceptive preparations on the normal leucocyte count. Br J Haematol (1970) 1.49
Effect of oestrogens on human platelet behaviour. Lancet (1968) 1.49
Use of isolated perfused organs in hypoxia and ischemia/reperfusion oxidant stress. Methods Enzymol (1990) 1.46
Patients' and general practitioners' satisfaction with information given on discharge from hospital: audit of a new information card. BMJ (1989) 1.45
Relation of low diastolic blood pressure to coronary heart disease death in presence of myocardial infarction: the Framingham Study. BMJ (1991) 1.44
Acetaminophen-induced hepatic necrosis. V. Correlation of hepatic necrosis, covalent binding and glutathione depletion in hamsters. Pharmacology (1974) 1.43
Progress in hepatology. Metabolic activation of drugs to toxic substances. Gastroenterology (1975) 1.42
Remodeling and reparation of the cardiovascular system. J Am Coll Cardiol (1992) 1.41
Cardioselective and non-cardioselective beta-blockers in reversible obstructive airways disease. Postgrad Med J (1977) 1.40
The J curve lives. Lancet (1992) 1.40
Reactive oxygen species during ischemia-reflow injury in isolated perfused rat liver. J Clin Invest (1988) 1.38
Parent and peer attachment in early adolescent depression. J Abnorm Child Psychol (1990) 1.38
Isoniazid and iproniazid: activation of metabolites to toxic intermediates in man and rat. Science (1976) 1.38
Magnetization transfer and multicomponent T2 relaxation measurements with histopathologic correlation in an experimental model of MS. J Magn Reson Imaging (2000) 1.37
Anticoagulants in coronary heart disease--retrospect and prospect. Lancet (1981) 1.36
Flexibility of the shoulder joint measured as range of abduction in a large representative sample of men and women over 65 years of age. Eur J Appl Physiol Occup Physiol (1989) 1.35
Platelet behaviour and drugs used in cardiovascular disease. Cardiovasc Res (1967) 1.32
Beta-blockers and asthma. Br Heart J (1978) 1.32
Abnormalities in platelet behaviour in acute illnesses. Br Med J (1966) 1.31
Treatment of high blood pressure: should clinical practice be based on results of clinical trials? Br Med J (Clin Res Ed) (1986) 1.31
Mechanism of action of N-acetylcysteine in the protection against the hepatotoxicity of acetaminophen in rats in vivo. J Clin Invest (1983) 1.31
Possible role of catecholamines, corticosteroids, and potassium in production of electrocardiographic abnormalities associated with subarachnoid haemorrhage. Br Heart J (1974) 1.28
Nature of the transferable factor which causes abnormal platelet behaviour in vascular disease. Lancet (1967) 1.27
Beneficial effects of adrenergic blockade in patients with subarachnoid haemorrhage. Br Med J (Clin Res Ed) (1982) 1.27
Clinical management of venous thrombo-embolism. Br Med Bull (1978) 1.26
Contribution of atenolol, bendrofluazide, and hydrallazine to management of severe hypertension. Br Med J (1977) 1.26
Organisation of the external region of the starch granule as determined by infrared spectroscopy. Int J Biol Macromol (2002) 1.26
Guanethidine and related agents. I. Mechanism of the selective blockade of adrenergic neurons and its antagonism by drugs. J Pharmacol Exp Ther (1970) 1.26
Timolol after myocardial infarction: an answer or a new set of questions? Br Med J (Clin Res Ed) (1981) 1.25
Platelet aggregation in whole blood determined using the Ultra-Flo 100 Platelet Counter. Thromb Haemost (1982) 1.25
Pilot studies on recombinant cold-adapted live type A and B influenza virus vaccines. J Infect Dis (1977) 1.25
Effects of N-acetylcysteine on acetaminophen covalent binding and hepatic necrosis in mice. J Pharmacol Exp Ther (1985) 1.24
Hepatic glutathione homeostasis in the rat: efflux accounts for glutathione turnover. Hepatology (1984) 1.23
Developments in understanding the basis of cooked-rice texture. Crit Rev Food Sci Nutr (2000) 1.23
Effect of oral contraceptive agents on platelets and plasma-phospholipids. Lancet (1968) 1.23
A comparison of four beta-adrenoceptor antagonists in patients with asthma. Br J Clin Pharmacol (1978) 1.22
Oestrogen treatment for menopausal flushing. Br Med J (1977) 1.21
Ischemic pain relief in patients with acute myocardial infarction by intravenous atenolol. Am Heart J (1982) 1.21
The clinical response to minocycline in multiple sclerosis is accompanied by beneficial immune changes: a pilot study. Mult Scler (2007) 1.18
Biliary excretion of glutathione and glutathione disulfide in the rat. Regulation and response to oxidative stress. J Clin Invest (1984) 1.18
Impact of particle size distribution on rheological and textural properties of chocolate models with reduced fat content. J Food Sci (2007) 1.18
Molecular basis for several drug-induced nephropathies. Am J Med (1977) 1.18
Acute pulmonary injury in rats by nitrofurantoin and modification by vitamin E, dietary fat, and oxygen. Am Rev Respir Dis (1979) 1.18
Neonatal platelet reactivity and serum thromboxane B2 production in whole blood: the effect of maternal low dose aspirin. Br J Obstet Gynaecol (1994) 1.18
Evidence that acetaminophen and N-hydroxyacetaminophen form a common arylating intermediate, N-acetyl-p-benzoquinoneimine. Mol Pharmacol (1980) 1.18
Beta-blockers and central nervous system side effects. Pharmacol Ther (1990) 1.17
Secondary prevention of myocardial infarction--the present state of the ART. Br Med J (1980) 1.16
Intravenous urography in the management of acute retention. Lancet (1977) 1.16